Affiliated Managers Group, Inc. (AMG) is a global asset management company with equity investments in leading boutique investment management firms. AMG's strategy is to generate shareholder value through the growth of existing affiliates, as well as through investments in new affiliates and additional investments in existing affiliates. In addition, AMG provides centralized assistance to its Affiliates in strategic matters, marketing, distribution, product development and operations. AMG's Affiliates offer over many investment products across a broad array of active, alpha-oriented strategies, to institutional and retail clients around the world. AMG offers investors a unique opportunity to participate in the growth of a diverse group of high quality boutique investment management firms. Through its Affiliates, AMG offers investment products across a wide range of investment styles and asset classes to mutual fund, institutional and high net worth investors....
+See More2019-09-19 15:30:00 Thursday ET
U.S. yield curve inversion can be a sign but not a root cause of the next economic recession. Treasury yield curve inversion helps predict each of the U.S.
2018-03-05 07:34:00 Monday ET
Peter Thiel shares his money views of President Trump, Facebook, Bitcoin, global finance, and trade etc. As an early technology adopter, Thiel invests in Fa
2018-02-23 09:35:00 Friday ET
Warren Buffett releases his annual letter to Berkshire Hathaway shareholders as of February 2018. Buffett discusses Berkshire's core cash ambition, its
2019-10-07 12:35:00 Monday ET
Federal Reserve reduces the interest rate by another key quarter point to the target range of 1.75%-2% in September 2019. In accordance with the Federal Res
2025-10-05 17:31:00 Sunday ET
Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be